Hyderabad: City-based Bharat Biotech on Monday announced that its Covid-19 intranasal vaccine iNCOVACC (BBV154) has received approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situation for ages 18 and above in India for heterologous booster doses. ...
NCDs leading cause of death among India's tribal population: ICMR study
'Public health at risk': Telangana IMA writes to health minister, opposes CPCH for Ayurveda practitioners
Neonatologist Dr Surya Prakash Hedda aims to give normal life to preterm babies
Can cold water baths cause strokes during winter? Here's what doctors say
Why more Indian youths are getting diagnosed with diabetes after Covid-19
Can over-exercising lead to heart attacks? Here's what experts have to say
Is there a link between Covid-19 and lung cancer? Experts explain
Is there an association between Covid 19 infection and auto-immune diseases?
Ghettoization of people with leprosy still prevalent: WHO goodwill ambassador Yohei Sasakawa
Winter favourable for spread of new Omicron sub-variants, warn experts
Explained: How Fatty Liver Index can help diagnose lifestyle diseases